(Q39505334)

English

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

I Elomaa

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

T Kylmälä

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

T Tammela

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J Viitanen

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J Ottelin

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

M Ruutu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

K Jauhiainen

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

M Ala-Opas

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

L Roos

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

J Seppänen

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

159-166

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Generalised increase in bone resorption in carcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the prostate. Hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy of prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of advanced prostatic cancer. Evaluation of response parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of painful bone lesions and hypercalcemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1385586

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02549644

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39505334&oldid=1832998227"